Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression

NCT06922994 is registered in ClinicalTrials.gov with Centro Cardiologico Monzino as lead sponsor.

NCT NCT06922994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06922994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression
Lead sponsor
Centro Cardiologico Monzino
Phase
Phase 2
Overall status
Recruiting
Start date
March 31, 2025
Completion date
November 30, 2026
Enrollment
102 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmogenic cardiomyopathy